Buy M&M; target of Rs 1060: India Infoline

Published on Tue, Nov 10, 2009 at 12:37 |  Source : Moneycontrol.com

Updated at Tue, Nov 10, 2009 at 12:48  

49052 Investors following Mah and Mah. Share this News with them.
0
0
Share on Tumblr
Buy M&M; target of Rs 1060: India Infoline

ALSO READ

India Infoline has recommended buy rating on Mahindra & Mahindra with a target of Rs 1060, in its November 10, 2009 research report.

"On Monday, Mahindra & Mahindra gave a bullish breakout by bouncing off sharply from its 50dma of Rs865. The immediate reaction took the stock towards the levels of Rs980. Since the second week of August, the stock has been moving in a channel were support was seen at Rs760 and resistance at Rs980. Monday's 3% upmove took the stock out from the above mentioned trading range. Other momentum oscillators are showing a positive build up. Based on above technical analysis, we recommend traders to buy the stock at current levels or up to the levels of Rs 1020 for an initial target of Rs 1060. It is advisable to maintain a stop loss of Rs 979 on all the long positions," says India Infoline research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment.........

Attachments : M&M_IndiaInfoline.pdf

  

More on Moneycontrol

Trending News

Business News

Apple rushing to finalize apps for iPad 3 announcement
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com